Detection of Chlamydia pneumonia and Mycoplasma pneumonia in hospitalised children with community acquired pneumonia


  • Kannan Ramamoorthy Department of pediatrics, Government Thiruvarur Medical College and Hospital, Thiruvarur, India
  • Agora Shivan Shanmuga Sundaram Department of pediatrics, Government Thiruvarur Medical College and Hospital, Thiruvarur, India



Chlamydia pneumonia, Community acquired pneumonia, ELISA, Mycoplasma pneumonia


Background: Mycoplasma pneumoniae and Chlamydia pneumoniae are atypical pathogens responsible for community acquired pneumonia (CAP) and are a leading cause of morbidity and mortality in low income countries. The study objective was to determine the prevalence of C. pneumoniae and M. pneumonia in hospitalized children with CAP.

Methods: This study was performed on ninety-four children admitted with radiologically confirmed diagnosis of pneumonia in Government Rajah Mirasudar Hospital, Thanjavur, during the period of July 2005 to April 2006. The diagnosis of infections with C. pneumonia and M. pneumonia was determined by detection of IgM antibody by using ELISA method. In this study clinical and radiological feature of these infections were also looked for.

Results: Among 94 children, 9 children (9.6%) were detected positive for M. pneumonia and 8 children (8.5%) were detected positive for C. pneumonia. Infection rate was highest among 5-12 years and least among 1 month to 24 months age group. The most common symptoms observed in patients with these pathogens are cough, fever, crepitations and rhonchi. Pulmonary infiltrates were the most common chest X-ray features of both C. pneumoniae pneumonia and M. pneumoniae pneumonia.

Conclusions: This study has shown that C. pneumonia and M. pneumonia play a significant role in paediatric CAP. Identification and confirmation of these organisms by IgM ELISA helps in better management that would decrease the need for hospitalization and IV antibiotics.


WHO. Acute respiratory infections in children. Case management in small hospitals in developing countries. A manual for Doctors and other senior health workers. WHO Geneva, 1990.

Patwari AK, Bisht S, Srinivasan A, Deb M, Chaittopadhya. Aetiology of pneumonia in hospitalized children. Trop Ped. 1996;42:15-20.

Kumar L. Severe acute lower respiratory infections: Etiology and management. Ind J Oediat. 1987;54:189-98.

Fernald GW, Clyde WA Jr. Epidemic pneumonia in university students. J Adolesc Health Care. 1989;10:520-6.

Nagayama Y, Sakurai N, Honda A, Makutam, Suzuki P. Isolation of M. pneumoniae from children with lower respiratory tract infections. Source J Infect Dis. 1988;157:911-7.

Yamada S. Chlamydia pneumonia infection in children with lower respiratory tract infections. Kurume Med J. 1995;42:107-20.

IBL International. Mycoplasma pneumoniae IgA ELISA. Available at Accessed on 12th March 2018.

Euroimmun. Chlamydia pneumonia IgM antibody. Available at: Accessed on 12 March 2018.

Foy HM, Loop J, Clarke ER, Mansy AW, Spence WF, Feigl P, et al. Radiographic study of M. pneumoniae pneumonia. Amer Rev Resp Dis. 1973;108:469-74.

Chaudhry R, Nazima N, Dhawan B, Kabra SK. Prevalence of Mycoplasma pneumoniae and Chlamydia. pneumoniae in children with community acquired pneumonia. Indian J Pediatr. 1998;65:717-21.

Block S, Hammerchlag HMR, Cassell GH, Craft JC. Mycoplasma pneumonia and Chlamydia pneumonia in paediatric community acquired pneumonia. Comparative efficacy and safety of Clarithromycin vs Erythromycin. Paediatr Infect Dis J. 1995;14:471-7.

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatr. 2004;113(4):701-7.

Foy HM, Grayston TJ, Kenny GE, Russell Alexander R, McMahan R. Epidemiology of Mycoplasma pneumoniae Infection in Families. JAMA. 1966;197(11):859-66.

Saikku P, Runtu P, Lenonen M. ALRTI associated C. TWAR Antibody in Fillipino Children. JL Infect Dis. 1988;158:1096-9.

Del Valle-Mendoza J, Orellana-Peralta F, Marcelo-Rodríguez A, Verne E, Esquivel-Vizcarra M, Silva-Caso W, Aguilar-Luis MA, et al. High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru. PLoS One. 2017;12(1):e0170787.

Charles T, McConnell Jr MD, Joseph F. Plouffe. Radiographic appearance of Chlamydia pneumonia (Twar Strain) in respiratory infections. Radiol. 1994;192:821-5.

Puljiz I, Kuzman I, Dakovic-Rode O, Schönwald N, Mise B. Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles. Epidemiol Infect. 2006;134(3):548-55.

Nelson CT. Mycoplasma and Chlamydia pneumonia in pediatrics. Semin Respir Infect. 2002;17:10-4.

Ruiz M, Ewig S, Marcos MA. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999;160:397-405.

File TM, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am. 1998;12:569-92.






Original Research Articles